Literature DB >> 15896403

Characterization of P gene-deficient rabies virus: propagation, pathogenicity and antigenicity.

Kinjiro Morimoto1, Youko Shoji, Satoshi Inoue.   

Abstract

The RNA polymerase of rabies virus (RV) is a two-protein complex composed of L (a large catalytic component) and P (a non-catalytic phosphoprotein cofactor) proteins. We generated a gene-deficient RV lacking the entire P gene from HEP-Flury (HEP) strain, one of the most attenuated RV strains, by the method of reverse genetics. This P gene-deficient (def-P) virus could replicate and produce progeny viruses with a slightly retarded rate in the cell lines that constitutively express the P protein. The def-P virus could perform the primary RNA transcription by the virion-associated polymerase even in the infected host without de novo P protein synthesis. However, the def-P virus required the newly synthesized P protein for the secondary RNA transcription and genome RNA replication of virus. No progeny virus was produced in the infected host that did not express P protein. The def-P virus was apathogenic in adult and suckling mice even when inoculated intracranially. On the other hand, inoculation of the def-P virus into mice induced a high titer of virus-neutralizing antibody and protected mice from lethal challenge with the CVS strain. These results demonstrated that the def-P virus could induce strong protective immunity against rabies virus without the production of progeny virus and the severe host damage. The def-P virus would be a potential resource of safe live-attenuated rabies vaccine.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15896403     DOI: 10.1016/j.virusres.2005.03.011

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  19 in total

1.  Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene.

Authors:  Jonathan Cenna; Gene S Tan; Amy B Papaneri; Bernhard Dietzschold; Matthias J Schnell; James P McGettigan
Journal:  Vaccine       Date:  2008-09-18       Impact factor: 3.641

2.  Reverse genetics of rabies virus: new strategies to attenuate virus virulence for vaccine development.

Authors:  Shimao Zhu; Hui Li; Chunhua Wang; Farui Luo; Caiping Guo
Journal:  J Neurovirol       Date:  2015-05-21       Impact factor: 2.643

Review 3.  Status of antiviral therapeutics against rabies virus and related emerging lyssaviruses.

Authors:  Venice Du Pont; Richard K Plemper; Matthias J Schnell
Journal:  Curr Opin Virol       Date:  2019-02-10       Impact factor: 7.090

4.  Rabies virus (RV) glycoprotein expression levels are not critical for pathogenicity of RV.

Authors:  Christoph Wirblich; Matthias J Schnell
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

5.  Attenuation of rabies virus replication and virulence by picornavirus internal ribosome entry site elements.

Authors:  Adriane Marschalek; Stefan Finke; Martin Schwemmle; Daniel Mayer; Bernd Heimrich; Lothar Stitz; Karl-Klaus Conzelmann
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

Review 6.  The cell biology of rabies virus: using stealth to reach the brain.

Authors:  Matthias J Schnell; James P McGettigan; Christoph Wirblich; Amy Papaneri
Journal:  Nat Rev Microbiol       Date:  2010-01       Impact factor: 60.633

7.  Replication-deficient rabies virus-based vaccines are safe and immunogenic in mice and nonhuman primates.

Authors:  Jonathan Cenna; Meredith Hunter; Gene S Tan; Amy B Papaneri; Erin P Ribka; Matthias J Schnell; Preston A Marx; James P McGettigan
Journal:  J Infect Dis       Date:  2009-10-15       Impact factor: 5.226

8.  Phenotypic Consequences In vivo and In vitro of Rearranging the P Gene of RABV HEP-Flury.

Authors:  Mingzhu Mei; Teng Long; Qiong Zhang; Jing Zhao; Qin Tian; Jiaojiao Peng; Jun Luo; Yifei Wang; Yingyi Lin; Xiaofeng Guo
Journal:  Front Microbiol       Date:  2017-02-03       Impact factor: 5.640

9.  Novel vaccines to human rabies.

Authors:  Hildegund C J Ertl
Journal:  PLoS Negl Trop Dis       Date:  2009-09-29

10.  Investigating the role for IL-21 in rabies virus vaccine-induced immunity.

Authors:  Corin L Dorfmeier; Evgeni P Tzvetkov; Anthony Gatt; James P McGettigan
Journal:  PLoS Negl Trop Dis       Date:  2013-03-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.